15 September 2020 SMC plays key role in helping to secure access to COVID-19 treatments The Scottish Medicines Consortium is part of a UK-wide multi-agency initiative to secure access to potential new treatments for COVID-19 to NHS patients quickly and safely.
7 September 2020 September 2020 decisions news release SMC accepts fourteen new medicines for use by NHSScotland The Scottish Medicines Consortium, (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 7 September) published advice accepting fourteen new medicines.
10 August 2020 August 2020 decisions news release SMC accepts breast cancer medicine for use by NHSScotland The Scottish Medicines Consortium, (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 10 August) published advice accepting neratinib (Nerlynx) for the treatment of breast cancer.
7 July 2020 SMC remobilisation Following the suspension of our Scottish Medicines Consortium (SMC), New Drugs Committee (NDC) and Patient and Clinician Engagement (PACE) meetings during the early stages of the COVID-19 pandemic, we are pleased to announce that we will be resuming meetings in the near future.
13 April 2020 April 2020 decisions news release SMC accepts four new medicines for use by NHSScotland The Scottish Medicines Consortium, (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 13 April) published advice accepting four new medicines.
9 March 2020 March 2020 decisions news release Advice on medicines for lung cancer, ovarian cancer, myotonia and leukaemia published by Scottish Medicines Consortium The Scottish Medicines Consortium, (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 9 March) published advice on four new medicines.
10 February 2020 February 2020 decisions news release Scottish Medicines Consortium publishes advice on six new medicines The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 10 February) published advice on six new medicines.
16 January 2020 Minor process changes introduced Paediatric licence extensions and fast track resubmission process introduced We will be introducing two minor process changes in January 2020.
13 January 2020 January 2020 decisions news release Medicines for prostate cancer, multiple sclerosis, lymphoma and migraine accepted for use by NHSScotland Medicines which can be used to treat prostate cancer, primary progressive multiple sclerosis, a rare form of lymphoma and migraine have today (Monday 13 January) been accepted by the Scottish Medicines Consortium (SMC) for use by NHSScotland.
